The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Genomic mutation profiling (GMP) and clinical outcome in patients (pts) treated with ribociclib (CDK4/6 inhibitor) in the Signature program.
 
Julio Antonio Peguero
Research Funding - EMD Serono (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Novartis (Inst)
 
Bert H. O'Neil
Consulting or Advisory Role - Acceleron Pharma; Amgen; Bayer; Genentech/Roche; Lilly/ImClone; Sanofi
Speakers' Bureau - Amgen
 
Davendra Sohal
Research Funding - Bayer (Inst); Celgene (Inst); Novartis (Inst); OncoMed (Inst)
 
Todd Michael Bauer
No Relationships to Disclose
 
Vivek Subbiah
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); NanoCarrier (Inst); Novartis (Inst)
 
Karen Kelly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Synta
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Lilly; Roche; Synta
 
Juneko E. Grilley-Olson
Consulting or Advisory Role - Sanofi
Research Funding - Bayer (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Kyowa Hakko Kirin (Inst); MedImmune (Inst); Morphotek (Inst); NanoCarrier (Inst); Novartis (Inst); Peregrine Pharmaceuticals (Inst); Seagen (Inst); ZIOPHARM Oncology (Inst)
 
Lincoln Nadauld
Stock and Other Ownership Interests - TOMA Biosciences
 
Howard Safran
No Relationships to Disclose
 
Eric Daniel Slosberg
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Rajinder Sidhu
No Relationships to Disclose
 
Erica Stealey
Employment - Novartis
 
Sudha Parasuraman
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Barinder Kang
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Joseph Paul Eder
Honoraria - Merck
Consulting or Advisory Role - Nektar
Travel, Accommodations, Expenses - Merck; Nektar